Pazopanib inhibits the activation of PDGFRβ-expressing astrocytes in the brain metastatic microenvironment of breast cancer cells
about
Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context.Pazopanib and HDAC inhibitors interact to kill sarcoma cells.Breast cancer brain metastases: evidence for neuronal-like adaptation in a 'breast-to-brain' transition?Role of the neural niche in brain metastatic cancer.In comparative analysis of multi-kinase inhibitors for targeted medulloblastoma therapy pazopanib exhibits promising in vitro and in vivo efficacy.Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines.Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanismBiology in prevention and treatment of brain metastases.Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy.Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update.Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.Overview of fundamental study of pazopanib in cancer.Targeting metastasis.Analysis of radiation therapy in a model of triple-negative breast cancer brain metastasis.Dynamics of PDGFRβ expression in different cell types after brain injury.Cancer-associated fibroblast promote transmigration through endothelial brain cells in three-dimensional in vitro models.Targeting protein quality control pathways in breast cancer.The biology and therapeutic management of melanoma brain metastases.Reactive Astrocytes in Brain Metastasis.Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.
P2860
Q30238959-C375F2A2-7D74-45C9-AFC3-0B7C08322C56Q33631472-1F2CC400-F7B8-4435-8254-C29BBC0CC08DQ33738679-869F4CA1-BAC1-4199-9C3C-82C80488E7E6Q34004215-373284E6-DC6B-423B-9BBD-EDCE567D00D8Q34334533-CD7359BA-8B76-4305-B2A7-FEEA52BF0AEEQ35551911-48F11536-338C-4298-9403-195B25EE806DQ36734590-EBADAB87-D0FF-4E5C-BB2C-5FB6FD4F1AD9Q38156192-D06E3AEE-3657-4103-81F0-68B9059E8B51Q38193533-EA374E7A-40E7-4942-85DD-179E936DBD2DQ38230553-3CB6D7DF-51AB-43D9-A5F7-66C8FAEA824DQ38385463-99CDD011-1CBD-42B6-9387-B8FA6F8FC765Q38696525-F9F34B96-0A07-4A8E-B486-36EBA08C5D57Q38786658-7885E70B-D994-4E63-9B4F-BF263F013314Q38839694-641C1DA6-92B2-4EBA-8D57-F5C67354F62CQ39251927-E4883B72-9D42-4856-BCEE-13D70293E97FQ40178500-E7CFA4F4-E3D5-43CF-B5C0-AC4D9BAD2109Q46087491-1D73ACDE-50DE-472B-AC50-CA4BD053C8C8Q47247953-DA2E4B33-9218-4A5D-B6B7-7C0DA886846AQ47875808-DC1E692D-79AA-43AE-85FF-E6205C0DFF2BQ51012619-40F61198-4446-4366-B26C-F6074897B804
P2860
Pazopanib inhibits the activation of PDGFRβ-expressing astrocytes in the brain metastatic microenvironment of breast cancer cells
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Pazopanib inhibits the activat ...... ronment of breast cancer cells
@en
type
label
Pazopanib inhibits the activat ...... ronment of breast cancer cells
@en
prefLabel
Pazopanib inhibits the activat ...... ronment of breast cancer cells
@en
P2093
P2860
P1476
Pazopanib inhibits the activat ...... ronment of breast cancer cells
@en
P2093
Brunilde Gril
Daniel Masana
David J Liewehr
Diane Palmieri
Fernando Vidal-Vanaclocha
Paloma Fernández
Patricia S Steeg
Seth M Steinberg
Talha Anwar
Yongzhen Qian
P2860
P304
P356
10.1016/J.AJPATH.2013.02.043
P407
P577
2013-04-12T00:00:00Z